|
Agent Type:
|
Semisynthetic; Small molecule; Direct acting;
|
|
Spectrum of activity:
|
Antimycobacterial
|
|
Mechanism of action:
|
Efflux pump inhibitor. Likely involves Mmr efflux pump as resistant isolates show upregulation
|
|
Target Pathogen:
|
Active against Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium kansasii, and Mycobacterium smegmatis
|
|
Propensity to select resistant mutants:
|
Yes
|
|
Description:
|
Semi-synthetic compound; derived from the natural product sanguinarine from Sanguinaria canadensis; bacteriostatic
|
|
Year first mentioned:
|
2024
|
|
Development status:
|
Experimental
|